CoChat

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques

Open access

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial receptor that recognizes changes in the lipid microenvironment, which may occur during amyloid β (Aβ) accumulation and neuronal degeneration in Alzheimer’s disease (AD). Rare TREM2 variants that affect TREM2 function lead to an increased risk of developing AD. In murine models of AD, TREM2 deficiency prevents microglial clustering around Aβ deposits. However, the origin of myeloid cells surrounding amyloid and the impact of TREM2 on Aβ accumulation are a matter of debate. Using parabiosis, we found that amyloid-associated myeloid cells derive from brain-resident microglia rather than from recruitment of peripheral blood monocytes. To determine the impact of TREM2 deficiency on Aβ accumulation, we examined Aβ plaques in the 5XFAD model of AD at the onset of Aβ-related pathology. At this early time point, Aβ accumulation was similar in TREM2-deficient and -sufficient 5XFAD mice. However, in the absence of TREM2, Aβ plaques were not fully enclosed by microglia; they were more diffuse, less dense, and were associated with significantly greater neuritic damage. Thus, TREM2 protects from AD by enabling microglia to surround and alter Aβ plaque structure, thereby limiting neuritic damage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20151948

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Lack of monocyte contribution to amyloid-associated microglia. (A) Surface expression of TREM2 among Ly6C+CD11b+CD115+ blood monocytes in WT and 5XFAD mice. Trem2−/− mice were used as negative controls. (B–E) Parabiosis was performed by joining blood circulation of 4- or 8-mo-old 5XFAD with age matched B6.CD45.1 congenic mice for 4 wk. (B) CD45+ blood leukocytes, CD11c+SiglecF+ lung alveolar macrophages, and brain CD11b+F4/80+ microglia from parabionts were analyzed by flow cytometry. (C) Frequencies of CD45.1+ and CD45.2+ cells were compared in parabiotic partners. (D and E) Representative images of brain sections of an 8-mo-old 5XFAD parabiont stained with X-34 (red) for Aβ plaques and Iba-1 (white) for microglia. Contribution of host- and donor-derived microglia was examined using antibodies specific for CD45.2 (green; D) and CD45.1 (green; E). Nuclei were visualized with To-pro3 (blue). Bar, 100 µm (F and G) Parabiosis was performed using APPPS1-21 mice and age-matched B6.CD45.1 congenic mice for 9 wk. Parabionts were analyzed as described above. Data represent a total of five to seven mice per group in A–E and four mice per group in F and G.
Figure 1. Lack of monocyte contribution to amyloid-associated microglia. (A) Surface expression of TREM2 among Ly6C+CD11b+CD115+ blood monocytes in WT and 5XFAD mice. Trem2−/− mice were used as negative controls. (B–E) Parabiosis was performed by joining blood circulation of 4- or 8-mo-old 5XFAD with age matched B6.CD45.1 congenic mice for 4 wk. (B) CD45+ blood leukocytes, CD11c+SiglecF+ lung alveolar macrophages, and brain CD11b+F4/80+ microglia from parabionts were analyzed by flow cytometry. (C) Frequencies of CD45.1+ and CD45.2+ cells were compared in parabiotic partners. (D and E) Representative images of brain sections of an 8-mo-old 5XFAD parabiont stained with X-34 (red) for Aβ plaques and Iba-1 (white) for microglia. Contribution of host- and donor-derived microglia was examined using antibodies specific for CD45.2 (green; D) and CD45.1 (green; E). Nuclei were visualized with To-pro3 (blue). Bar, 100 µm (F and G) Parabiosis was performed using APPPS1-21 mice and age-matched B6.CD45.1 congenic mice for 9 wk. Parabionts were analyzed as described above. Data represent a total of five to seven mice per group in A–E and four mice per group in F and G.CC BY-NC-SA · PubMed Central
Figure 2. Impaired microglial response to Aβ deposits in Trem2−/− 5XFAD mice is apparent by 4 mo. (A) Total numbers of microglia in the cortices and hippocampi of 5XFAD and Trem2−/− 5XFAD mice at 4 and 8 mo of age. (B and C) Microglial response to Aβ plaques in 4-mo-ol 5XFAD, Trem2+/− 5XFAD, and Trem2−/−5XFAD mice. (B) Representative images show matching cortical regions stained with X-34 (red) for amyloid plaques and Iba-1 (white) for microglia. Nuclei were visualized with To-pro3 (blue). (C) Numbers of microglia within 15 or 30 µm of Aβ plaques. (D–F) Microglia proliferation in 5XFAD and Trem2−/− 5XFAD mice was assessed by determining nuclear localization of Ki-67. (D) Representative sectional view of a confocal image shows expression of Ki-67 (green), microglia (Iba-1; white), and nuclei (blue). The proximity of Ki-67+ microglia to Aβ plaques (X-34, red), in cortices of 5XFAD mice is visualized. (E) Proximity of Ki-67+ microglia to the nearest plaque in cortices of 5XFAD. Unfilled circles (*) represent outliers as determined by q-test. (F) Frequencies of Ki-67+ microglia per HPF in 5XFAD and Trem2−/−5XFAD mice. (G) The volume of all observed Aβ plaques and Aβ plaques with Ki-67+ in close proximity were compared. (H) The log10-transformed volume of plaques was plotted against the number of microglia within 15 µm. Numbers represent slope ±95% confidence interval. (I and J) 5XFAD and Trem2−/− 5XFAD mice were injected with methoxy-X04 and the percentage of microglia with internalized methoxy-X04 (indicative of fibrillar Aβ) was determined by flow cytometry. (I) Representative plots show methoxy-x04 positivity of CD11b+CD45lo cells. APP transgene negative (APP–) littermates were used as negative controls. (J) The frequency of methoxy-X04+ microglia was quantified. Bars: (B) 100 µm; (D) 20 µm. Error bar represents mean ± SEM. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001, Mann-Whitney (A, F, and J) and q-test (E). Data represent a total of five to seven mice per group (A–F). For confocal images, a total of four random HPF were analyzed per mouse.
Figure 2. Impaired microglial response to Aβ deposits in Trem2−/− 5XFAD mice is apparent by 4 mo. (A) Total numbers of microglia in the cortices and hippocampi of 5XFAD and Trem2−/− 5XFAD mice at 4 and 8 mo of age. (B and C) Microglial response to Aβ plaques in 4-mo-ol 5XFAD, Trem2+/− 5XFAD, and Trem2−/−5XFAD mice. (B) Representative images show matching cortical regions stained with X-34 (red) for amyloid plaques and Iba-1 (white) for microglia. Nuclei were visualized with To-pro3 (blue). (C) Numbers of microglia within 15 or 30 µm of Aβ plaques. (D–F) Microglia proliferation in 5XFAD and Trem2−/− 5XFAD mice was assessed by determining nuclear localization of Ki-67. (D) Representative sectional view of a confocal image shows expression of Ki-67 (green), microglia (Iba-1; white), and nuclei (blue). The proximity of Ki-67+ microglia to Aβ plaques (X-34, red), in cortices of 5XFAD mice is visualized. (E) Proximity of Ki-67+ microglia to the nearest plaque in cortices of 5XFAD. Unfilled circles (*) represent outliers as determined by q-test. (F) Frequencies of Ki-67+ microglia per HPF in 5XFAD and Trem2−/−5XFAD mice. (G) The volume of all observed Aβ plaques and Aβ plaques with Ki-67+ in close proximity were compared. (H) The log10-transformed volume of plaques was plotted against the number of microglia within 15 µm. Numbers represent slope ±95% confidence interval. (I and J) 5XFAD and Trem2−/− 5XFAD mice were injected with methoxy-X04 and the percentage of microglia with internalized methoxy-X04 (indicative of fibrillar Aβ) was determined by flow cytometry. (I) Representative plots show methoxy-x04 positivity of CD11b+CD45lo cells. APP transgene negative (APP–) littermates were used as negative controls. (J) The frequency of methoxy-X04+ microglia was quantified. Bars: (B) 100 µm; (D) 20 µm. Error bar represents mean ± SEM. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001, Mann-Whitney (A, F, and J) and q-test (E). Data represent a total of five to seven mice per group (A–F). For confocal images, a total of four random HPF were analyzed per mouse.CC BY-NC-SA · PubMed Central
Figure 3. TREM2 deficiency alters physical appearance and biochemical composition of amyloid plaques. (A–D) Accumulation of insoluble Aβ1-42 (A and B) and Aβ1-40 (C and D) in the cortices and hippocampi of 4-mo-old 5XFAD, Trem2+/−5XFAD, and Trem2−/−5XFAD mice was determined by ELISA. (E) Deposition of fibrillar Aβ in the cortices determined by X-34 staining. Levels of X-34 signal in the hippocampi were below the threshold of detection. (F–I) Morphology of fibrillar plaques in 4-mo-old 5XFAD and Trem2−/−5XFAD mice. X-34–reactive fibrillar plaques were visualized using high-resolution confocal microscopy (F) and converted to heat-map images based on pixel intensity (H). Physical appearance of X-34-reactive fibrillar plaques was further quantified based on morphology (G) and pixel intensity (I). Diffuse shape and reduced density were also apparent in 8-mo-old Trem2−/−5XFAD mice (F and H). (J) Representative urea immunoblots showing the detection of Aβ1-42, Aβ1-42+1, Aβ1-42-1, Aβ1-42-2, and Aβp3-42 from insoluble fractions of hippocampi from 5XFAD mice. (K) Quantification of insoluble Aβ species by urea immunoblots in the cortices and hippocampi of 5XFAD, Trem2+/−5XFAD, and Trem2−/−5XFAD mice. Abundance of Aβ1-42+1, Aβ1-42-1, Aβ1-42-2, and Aβp3-42 relative to Aβ1-42 is shown. Amount of Aβ used for standard curves are indicated. Bar, 10 µm. *, P < 0.05; ** P < 0.01; ****, P < 0.0001, Mann-Whitney (G and I), two-way ANOVA (E and K). Data represent a total of 8–14 mice per group in A–E, eight mice per group in F–I and five mice per group in K. For confocal images, a total of four random HPF were analyzed per mouse. Error bar represents mean ± SEM.
Figure 3. TREM2 deficiency alters physical appearance and biochemical composition of amyloid plaques. (A–D) Accumulation of insoluble Aβ1-42 (A and B) and Aβ1-40 (C and D) in the cortices and hippocampi of 4-mo-old 5XFAD, Trem2+/−5XFAD, and Trem2−/−5XFAD mice was determined by ELISA. (E) Deposition of fibrillar Aβ in the cortices determined by X-34 staining. Levels of X-34 signal in the hippocampi were below the threshold of detection. (F–I) Morphology of fibrillar plaques in 4-mo-old 5XFAD and Trem2−/−5XFAD mice. X-34–reactive fibrillar plaques were visualized using high-resolution confocal microscopy (F) and converted to heat-map images based on pixel intensity (H). Physical appearance of X-34-reactive fibrillar plaques was further quantified based on morphology (G) and pixel intensity (I). Diffuse shape and reduced density were also apparent in 8-mo-old Trem2−/−5XFAD mice (F and H). (J) Representative urea immunoblots showing the detection of Aβ1-42, Aβ1-42+1, Aβ1-42-1, Aβ1-42-2, and Aβp3-42 from insoluble fractions of hippocampi from 5XFAD mice. (K) Quantification of insoluble Aβ species by urea immunoblots in the cortices and hippocampi of 5XFAD, Trem2+/−5XFAD, and Trem2−/−5XFAD mice. Abundance of Aβ1-42+1, Aβ1-42-1, Aβ1-42-2, and Aβp3-42 relative to Aβ1-42 is shown. Amount of Aβ used for standard curves are indicated. Bar, 10 µm. *, P < 0.05; ** P < 0.01; ****, P < 0.0001, Mann-Whitney (G and I), two-way ANOVA (E and K). Data represent a total of 8–14 mice per group in A–E, eight mice per group in F–I and five mice per group in K. For confocal images, a total of four random HPF were analyzed per mouse. Error bar represents mean ± SEM.CC BY-NC-SA · PubMed Central
Figure 4. Neuritic dystrophy and the amounts of phospho-tau in proximity to plaques are markedly increased in the absence of TREM2. (A–C) Neuritic dystrophy in 5XFAD and Trem2−/−5XFAD mice was visualized using 22C11 mAb against the APP N terminus (APP-NT). (A) Representative images show APP-NT+ neurites (green), Aβ plaques (X-34; red), and nuclei (To-pro3; blue). (B and C) Quantification of total volume and numbers of APP-NT+ neurites within 30 µm of Aβ plaques. (D–F) Hyperphosphorylated tau in 5XFAD and Trem2−/−5XFAD mice. Sections were stained with anti–phospho-tau antibody (AT8; green) and Aβ plaques (red; D). Total volume of AT8+ neurites (E) and the number of AT8+ spots per HPF (F) were quantified. Bar, 20 µm. *, P < 0.05; ****, P < 0.0001, by Mann-Whitney. Data represent a total of four to eight mice per group. For confocal images, a total of four random HPF were analyzed per mouse. Error bar represents mean ± SEM.
Figure 4. Neuritic dystrophy and the amounts of phospho-tau in proximity to plaques are markedly increased in the absence of TREM2. (A–C) Neuritic dystrophy in 5XFAD and Trem2−/−5XFAD mice was visualized using 22C11 mAb against the APP N terminus (APP-NT). (A) Representative images show APP-NT+ neurites (green), Aβ plaques (X-34; red), and nuclei (To-pro3; blue). (B and C) Quantification of total volume and numbers of APP-NT+ neurites within 30 µm of Aβ plaques. (D–F) Hyperphosphorylated tau in 5XFAD and Trem2−/−5XFAD mice. Sections were stained with anti–phospho-tau antibody (AT8; green) and Aβ plaques (red; D). Total volume of AT8+ neurites (E) and the number of AT8+ spots per HPF (F) were quantified. Bar, 20 µm. *, P < 0.05; ****, P < 0.0001, by Mann-Whitney. Data represent a total of four to eight mice per group. For confocal images, a total of four random HPF were analyzed per mouse. Error bar represents mean ± SEM.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

42 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 840

Metadata

Authors
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., Cella, M., Grutzendler, J., DeMattos, R. B., Cirrito, J. R., Holtzman, D. M., & Colonna, M.
Affiliations
  • Eli Lilly (United States) (US)
  • Washington University in St. Louis (US)
  • Yale University (US)
Corresponding author
Colonna, Marco
Venue
Journal of Experimental Medicine
Published
2016-04-18
Volume
213
Issue
5
Pages
667-675
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2339534121
Cited by
840
References
32
Citations by year
2026: 62 · 2025: 76 · 2024: 86 · 2023: 106 · 2022: 114 · 2021: 102 · 2020: 93 · 2019: 73 · 2018: 61 · 2017: 50 · 2016: 16
FWCI
36.27
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders
  • Eli Lilly and Company
  • National Institutes of Health (RF1 AG05148501, 5T32CA009547-30, AG047644)
  • National Multiple Sclerosis Society (RG4687A1/1)
  • Cure Alzheimer’s Fund
  • JPB Foundation
  • Knight Alzheimer’s Disease Research Center (P50 AG005681-30)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
TREM2, microglia, amyloid plaques, Alzheimer's disease, parabiosis, 5xFAD mice, TREM2 deficiency, lipid microenvironment, peripheral blood monocytes
MeSH terms
Alzheimer Disease, Animals, Disease Models, Animal, Humans, Membrane Glycoproteins, Monocytes, Receptors, Immunologic, Amyloid beta-Peptides, Neurites, Microglia, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. https://app.cochat.ai/papers/10.1084/jem.20151948
The paper
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., Cella, M., Grutzendler, J., DeMattos, R. B., Cirrito, J. R., Holtzman, D. M., & Colonna, M. (2016). TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20151948

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.